Akkermansia muciniphila

Akkermansia Muciniphila for Depression: Lipid Pathway Links Gut, Liver & Brain

Depression is far more than a psychological issue — it is a systemic metabolic disorder connecting gut, liver, and brain. A landmark 2026 study published in Frontiers in Pharmacology (PMID: 41993570) confirms that Akkermansia muciniphila alleviates depression by activating a critical glycerophospholipid metabolism pathway that synchronously repairs the gut, liver, and brain. This research uncovers […]

Akkermansia Muciniphila for Depression: Lipid Pathway Links Gut, Liver & Brain Read Post »

2026 New Clinical Evidence: Pasteurized Akkermansia Muciniphila Mucᵀ for Sustainable Weight Loss Maintenance & Metabolic Health

Akkermansia muciniphila weight loss maintenance is validated by the latest 2026 Nature Medicine randomized controlled trial. Published May 13, 2026, a groundbreaking randomized controlled trial in Nature Medicine delivers the latest gold‑standard human clinical proof that pasteurized Akkermansia muciniphila Mucᵀ is the most effective gut postbiotic for long‑term weight loss maintenance and metabolic wellness. For

2026 New Clinical Evidence: Pasteurized Akkermansia Muciniphila Mucᵀ for Sustainable Weight Loss Maintenance & Metabolic Health Read Post »